| P2093 | author name string | J van der Zee | |
| P2860 | cites work | Fast spectroscopic imaging for non-invasive thermometry using the Pr[MOE-DO3A] complex | Q30583193 |
| | Reirradiation combined with hyperthermia in recurrent breast cancer results in a worthwhile local palliation | Q33177386 |
| | Comparison of the clinical effectiveness of the 433 MHz Lucite cone applicator with that of a conventional waveguide applicator in applications of superficial hyperthermia | Q33177647 |
| | The Dutch Deep Hyperthermia Trial: results in cervical cancer | Q33183327 |
| | A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer | Q33337475 |
| | Hyperthermia treatment planning | Q33937266 |
| | Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer | Q33994410 |
| | Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. | Q34744991 |
| | The effect of hyperthermia in combination with melphalan on drug-sensitive and drug-resistant CHO cells in vitro | Q35983084 |
| | The effect of systemic hyperthermia on melphalan pharmacokinetics in mice | Q35991613 |
| | Hyperthermic isolation limb perfusion for malignant melanoma: a review | Q36311103 |
| | A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervix | Q36620366 |
| | Effect of hyperthermia on the central nervous system: a review | Q40734266 |
| | A novel drug to reduce tumor perfusion: antitumor effect alone and with hyperthermia | Q40863520 |
| | Superficial hyperthermia and irradiation for recurrent breast carcinoma of the chest wall: prognostic factors in 196 tumors | Q40870693 |
| | Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase II clinical trial | Q41732142 |
| | Local hyperthermia, radiation, and chemotherapy in recurrent breast cancer is feasible and effective except for inflammatory disease | Q43564746 |
| | Combretastatin A-4 and hyperthermia;a potent combination for the treatment of solid tumors | Q43663314 |
| | Improving local tumor control by combining vascular targeting drugs, mild hyperthermia and radiation | Q43706476 |
| | Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study | Q43723207 |
| | Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia | Q43723209 |
| | The therapeutic advantage of combined heat and X rays on a mouse fibrosarcoma | Q44239344 |
| | Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway | Q44539124 |
| | Heat-inducible vectors for use in gene therapy | Q45866730 |
| | Enhancement of radiotherapy by hyperthermia-regulated gene therapy | Q45873183 |
| | Vinblastine and hyperthermia target the neovasculature in BT(4)AN rat gliomas: therapeutic implications of the vascular phenotype | Q48784777 |
| | Adenovirus-mediated transfer of p53 augments hyperthermia-induced apoptosis in U251 glioma cells. | Q50505249 |
| | Systemic Hyperthermia Oncological Working Group. 1st annual meeting, New York, N.Y., USA. June 7-8, 1994. | Q50596383 |
| | Clinical evaluation and verification of the hyperthermia treatment planning system hyperplan. | Q52112654 |
| | Simulation studies promote technological development of radiofrequency phased array hyperthermia. | Q52302066 |
| | Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectively controlled randomized study by the Radiation Therapy Group. | Q54546407 |
| | Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia. | Q55473824 |
| | Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma | Q57618625 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| P304 | page(s) | 1173-1184 | |
| P577 | publication date | 2002-08-01 | |
| P1433 | published in | Annals of Oncology | Q326122 |
| P1476 | title | Heating the patient: a promising approach? | |
| P478 | volume | 13 | |